S10 of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol 179:739-747, 2017. 16. Zinzani PL, Santoro A, Gritti G, et al: Nivolumab Combined With Brentuximab Vedotin for Relapsed/ Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study. J Clin Oncol 37:3081-3089, 2019. 17. Crombie JL, Nastoupil LJ, Redd R, et al: Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma. Blood Adv 5:35633567, 2021.
RkJQdWJsaXNoZXIy MTk3NTQxMg==